Economic TimesLean R·
Avience Biomedicals IPO: Check GMP, price band and other details
The grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against the upper end of the issue band, a premium of roughly Rs 75 per share. A GMP of this magnitude points to strong pre-listing demand and suggests investors are pricing in a healthy listing-day gain, a sharp contrast to the muted grey market activity seen in several other SME issues opening this week.
Read at Economic Times →
